U.S. Tariffs vs Pharma: A Closer Look

U.S. Tariffs vs Pharma: A Closer Look

Navigating Pharma’s Future Amid Rising Tariffs and Supply Chain Shifts

As global trade tensions escalate under the second Trump administration, the U.S. pharmaceutical and clinical research industries are bracing for impact. A new wave of proposed tariffs threatens to raise the cost of critical components, from active pharmaceutical ingredients (APIs) and lab reagents to diagnostic devices, with potentially serious implications for R&D pipelines, drug pricing, […]

Leave Us A Message

Cookie Consent with Real Cookie Banner